112 related articles for article (PubMed ID: 21438833)
1. Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics.
Toman I; Loree J; Klimowicz AC; Bahlis N; Lai R; Belch A; Pilarski L; Reiman T
Leuk Lymphoma; 2011 Apr; 52(4):659-67. PubMed ID: 21438833
[TBL] [Abstract][Full Text] [Related]
2. Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers.
Yin L; Xu J; Li M; Reddy V; Zhou Q; Liu H; Chu P; Zhang Q; Huang Q; Gao Z; Liang X; Wang HY; Pan Z
Histopathology; 2016 Nov; 69(5):775-783. PubMed ID: 27319306
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
Kara IO; Duman BB; Afsar CU
J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
[TBL] [Abstract][Full Text] [Related]
5. CD138
Wu D; Zhang P; Li F; Shen Y; Chen H; Feng Y; He A; Wang F
Aging (Albany NY); 2020 Nov; 12(22):23067-23081. PubMed ID: 33197893
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Notch1 on the membrane of bone marrow CD38(+)CD138(+) plasma cells in the patients with multiple myeloma].
Zhao YR; Fu R; Guan J; Gao S; Liu H; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Wang J; Li LJ; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):274-7. PubMed ID: 22781716
[TBL] [Abstract][Full Text] [Related]
7. Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.
Cavazzini F; De Wolf-Peeters C; Wlodarska I
Cancer Genet Cytogenet; 2005 Apr; 158(2):167-71. PubMed ID: 15796964
[TBL] [Abstract][Full Text] [Related]
8. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract][Full Text] [Related]
9. A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility.
Misiewicz-Krzeminska I; Corchete LA; Rojas EA; Martínez-López J; García-Sanz R; Oriol A; Bladé J; Lahuerta JJ; Miguel JS; Mateos MV; Gutiérrez NC
Haematologica; 2018 May; 103(5):880-889. PubMed ID: 29545347
[TBL] [Abstract][Full Text] [Related]
10. CD138
Shuai W; Li S
Blood; 2019 Sep; 134(11):906. PubMed ID: 31515228
[No Abstract] [Full Text] [Related]
11. Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis.
Martello M; Remondini D; Borsi E; Santacroce B; Procacci M; Pezzi A; Dico FA; Martinelli G; Zamagni E; Tacchetti P; Pantani L; Testoni N; Marzocchi G; Rocchi S; Zannetti BA; Mancuso K; Cavo M; Terragna C
Leukemia; 2016 Sep; 30(9):1869-76. PubMed ID: 27074969
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
13. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.
Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK
Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757
[TBL] [Abstract][Full Text] [Related]
15. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
17. miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
Papadimitriou MA; Papanota AM; Adamopoulos PG; Pilala KM; Liacos CI; Malandrakis P; Mavrianou-Koutsoukou N; Patseas D; Eleutherakis-Papaiakovou E; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Terpos E; Scorilas A
Br J Cancer; 2022 Jan; 126(1):79-90. PubMed ID: 34718359
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.
Cook JR; Hartke M; Pettay J; Tubbs RR
J Mol Diagn; 2006 Sep; 8(4):459-65. PubMed ID: 16931586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]